Global Dendritic Cell Vaccine Supply, Demand and Key Producers, 2023-2029

Page: 119

Published Date: 06 Sep 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

The global Dendritic Cell Vaccine market size is expected to reach $ 80 million by 2029, rising at a market growth of 3.0% CAGR during the forecast period (2023-2029).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of prostate cancer, this technology has become a promising new therapeutic option.

This report studies the global Dendritic Cell Vaccine production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Dendritic Cell Vaccine, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dendritic Cell Vaccine that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Dendritic Cell Vaccine total production and demand, 2018-2029, (K Units)
Global Dendritic Cell Vaccine total production value, 2018-2029, (USD Million)
Global Dendritic Cell Vaccine production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Dendritic Cell Vaccine consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Dendritic Cell Vaccine domestic production, consumption, key domestic manufacturers and share
Global Dendritic Cell Vaccine production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Dendritic Cell Vaccine production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Dendritic Cell Vaccine production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global Dendritic Cell Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include 3M, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime and Sanpower Corporation (Dendreon Corporation), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Dendritic Cell Vaccine market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Dendritic Cell Vaccine Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Dendritic Cell Vaccine Market, Segmentation by Type
Non-Targeted
Target

Global Dendritic Cell Vaccine Market, Segmentation by Application
Covid-19
Cancer
Others

Companies Profiled:
3M
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation (Dendreon Corporation)
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck & Co.

Key Questions Answered
1. How big is the global Dendritic Cell Vaccine market?
2. What is the demand of the global Dendritic Cell Vaccine market?
3. What is the year over year growth of the global Dendritic Cell Vaccine market?
4. What is the production and production value of the global Dendritic Cell Vaccine market?
5. Who are the key producers in the global Dendritic Cell Vaccine market?

Table of Contents

1 Supply Summary
    1.1 Dendritic Cell Vaccine Introduction
    1.2 World Dendritic Cell Vaccine Supply & Forecast
        1.2.1 World Dendritic Cell Vaccine Production Value (2018 & 2022 & 2029)
        1.2.2 World Dendritic Cell Vaccine Production (2018-2029)
        1.2.3 World Dendritic Cell Vaccine Pricing Trends (2018-2029)
    1.3 World Dendritic Cell Vaccine Production by Region (Based on Production Site)
        1.3.1 World Dendritic Cell Vaccine Production Value by Region (2018-2029)
        1.3.2 World Dendritic Cell Vaccine Production by Region (2018-2029)
        1.3.3 World Dendritic Cell Vaccine Average Price by Region (2018-2029)
        1.3.4 North America Dendritic Cell Vaccine Production (2018-2029)
        1.3.5 Europe Dendritic Cell Vaccine Production (2018-2029)
        1.3.6 China Dendritic Cell Vaccine Production (2018-2029)
        1.3.7 Japan Dendritic Cell Vaccine Production (2018-2029)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Dendritic Cell Vaccine Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Dendritic Cell Vaccine Major Market Trends

2 Demand Summary
    2.1 World Dendritic Cell Vaccine Demand (2018-2029)
    2.2 World Dendritic Cell Vaccine Consumption by Region
        2.2.1 World Dendritic Cell Vaccine Consumption by Region (2018-2023)
        2.2.2 World Dendritic Cell Vaccine Consumption Forecast by Region (2024-2029)
    2.3 United States Dendritic Cell Vaccine Consumption (2018-2029)
    2.4 China Dendritic Cell Vaccine Consumption (2018-2029)
    2.5 Europe Dendritic Cell Vaccine Consumption (2018-2029)
    2.6 Japan Dendritic Cell Vaccine Consumption (2018-2029)
    2.7 South Korea Dendritic Cell Vaccine Consumption (2018-2029)
    2.8 ASEAN Dendritic Cell Vaccine Consumption (2018-2029)
    2.9 India Dendritic Cell Vaccine Consumption (2018-2029)

3 World Dendritic Cell Vaccine Manufacturers Competitive Analysis
    3.1 World Dendritic Cell Vaccine Production Value by Manufacturer (2018-2023)
    3.2 World Dendritic Cell Vaccine Production by Manufacturer (2018-2023)
    3.3 World Dendritic Cell Vaccine Average Price by Manufacturer (2018-2023)
    3.4 Dendritic Cell Vaccine Company Evaluation Quadrant
    3.5 Industry Rank and Concentration Rate (CR)
        3.5.1 Global Dendritic Cell Vaccine Industry Rank of Major Manufacturers
        3.5.2 Global Concentration Ratios (CR4) for Dendritic Cell Vaccine in 2022
        3.5.3 Global Concentration Ratios (CR8) for Dendritic Cell Vaccine in 2022
    3.6 Dendritic Cell Vaccine Market: Overall Company Footprint Analysis
        3.6.1 Dendritic Cell Vaccine Market: Region Footprint
        3.6.2 Dendritic Cell Vaccine Market: Company Product Type Footprint
        3.6.3 Dendritic Cell Vaccine Market: Company Product Application Footprint
    3.7 Competitive Environment
        3.7.1 Historical Structure of the Industry
        3.7.2 Barriers of Market Entry
        3.7.3 Factors of Competition
    3.8 New Entrant and Capacity Expansion Plans
    3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
    4.1 United States VS China: Dendritic Cell Vaccine Production Value Comparison
        4.1.1 United States VS China: Dendritic Cell Vaccine Production Value Comparison (2018 & 2022 & 2029)
        4.1.2 United States VS China: Dendritic Cell Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    4.2 United States VS China: Dendritic Cell Vaccine Production Comparison
        4.2.1 United States VS China: Dendritic Cell Vaccine Production Comparison (2018 & 2022 & 2029)
        4.2.2 United States VS China: Dendritic Cell Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    4.3 United States VS China: Dendritic Cell Vaccine Consumption Comparison
        4.3.1 United States VS China: Dendritic Cell Vaccine Consumption Comparison (2018 & 2022 & 2029)
        4.3.2 United States VS China: Dendritic Cell Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    4.4 United States Based Dendritic Cell Vaccine Manufacturers and Market Share, 2018-2023
        4.4.1 United States Based Dendritic Cell Vaccine Manufacturers, Headquarters and Production Site (States, Country)
        4.4.2 United States Based Manufacturers Dendritic Cell Vaccine Production Value (2018-2023)
        4.4.3 United States Based Manufacturers Dendritic Cell Vaccine Production (2018-2023)
    4.5 China Based Dendritic Cell Vaccine Manufacturers and Market Share
        4.5.1 China Based Dendritic Cell Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
        4.5.2 China Based Manufacturers Dendritic Cell Vaccine Production Value (2018-2023)
        4.5.3 China Based Manufacturers Dendritic Cell Vaccine Production (2018-2023)
    4.6 Rest of World Based Dendritic Cell Vaccine Manufacturers and Market Share, 2018-2023
        4.6.1 Rest of World Based Dendritic Cell Vaccine Manufacturers, Headquarters and Production Site (State, Country)
        4.6.2 Rest of World Based Manufacturers Dendritic Cell Vaccine Production Value (2018-2023)
        4.6.3 Rest of World Based Manufacturers Dendritic Cell Vaccine Production (2018-2023)

5 Market Analysis by Type
    5.1 World Dendritic Cell Vaccine Market Size Overview by Type: 2018 VS 2022 VS 2029
    5.2 Segment Introduction by Type
        5.2.1 Non-Targeted
        5.2.2 Target
    5.3 Market Segment by Type
        5.3.1 World Dendritic Cell Vaccine Production by Type (2018-2029)
        5.3.2 World Dendritic Cell Vaccine Production Value by Type (2018-2029)
        5.3.3 World Dendritic Cell Vaccine Average Price by Type (2018-2029)

6 Market Analysis by Application
    6.1 World Dendritic Cell Vaccine Market Size Overview by Application: 2018 VS 2022 VS 2029
    6.2 Segment Introduction by Application
        6.2.1 Covid-19
        6.2.2 Cancer
        6.2.3 Others
    6.3 Market Segment by Application
        6.3.1 World Dendritic Cell Vaccine Production by Application (2018-2029)
        6.3.2 World Dendritic Cell Vaccine Production Value by Application (2018-2029)
        6.3.3 World Dendritic Cell Vaccine Average Price by Application (2018-2029)

7 Company Profiles
    7.1 3M
        7.1.1 3M Details
        7.1.2 3M Major Business
        7.1.3 3M Dendritic Cell Vaccine Product and Services
        7.1.4 3M Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.1.5 3M Recent Developments/Updates
        7.1.6 3M Competitive Strengths & Weaknesses
    7.2 Activarti
        7.2.1 Activarti Details
        7.2.2 Activarti Major Business
        7.2.3 Activarti Dendritic Cell Vaccine Product and Services
        7.2.4 Activarti Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.2.5 Activarti Recent Developments/Updates
        7.2.6 Activarti Competitive Strengths & Weaknesses
    7.3 Argos Therapeutics
        7.3.1 Argos Therapeutics Details
        7.3.2 Argos Therapeutics Major Business
        7.3.3 Argos Therapeutics Dendritic Cell Vaccine Product and Services
        7.3.4 Argos Therapeutics Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.3.5 Argos Therapeutics Recent Developments/Updates
        7.3.6 Argos Therapeutics Competitive Strengths & Weaknesses
    7.4 Batavia Bioservices
        7.4.1 Batavia Bioservices Details
        7.4.2 Batavia Bioservices Major Business
        7.4.3 Batavia Bioservices Dendritic Cell Vaccine Product and Services
        7.4.4 Batavia Bioservices Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.4.5 Batavia Bioservices Recent Developments/Updates
        7.4.6 Batavia Bioservices Competitive Strengths & Weaknesses
    7.5 Bellicum Pharmaceuticals
        7.5.1 Bellicum Pharmaceuticals Details
        7.5.2 Bellicum Pharmaceuticals Major Business
        7.5.3 Bellicum Pharmaceuticals Dendritic Cell Vaccine Product and Services
        7.5.4 Bellicum Pharmaceuticals Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.5.5 Bellicum Pharmaceuticals Recent Developments/Updates
        7.5.6 Bellicum Pharmaceuticals Competitive Strengths & Weaknesses
    7.6 Creagene
        7.6.1 Creagene Details
        7.6.2 Creagene Major Business
        7.6.3 Creagene Dendritic Cell Vaccine Product and Services
        7.6.4 Creagene Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.6.5 Creagene Recent Developments/Updates
        7.6.6 Creagene Competitive Strengths & Weaknesses
    7.7 DanDrit Biotech
        7.7.1 DanDrit Biotech Details
        7.7.2 DanDrit Biotech Major Business
        7.7.3 DanDrit Biotech Dendritic Cell Vaccine Product and Services
        7.7.4 DanDrit Biotech Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.7.5 DanDrit Biotech Recent Developments/Updates
        7.7.6 DanDrit Biotech Competitive Strengths & Weaknesses
    7.8 DCPrime
        7.8.1 DCPrime Details
        7.8.2 DCPrime Major Business
        7.8.3 DCPrime Dendritic Cell Vaccine Product and Services
        7.8.4 DCPrime Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.8.5 DCPrime Recent Developments/Updates
        7.8.6 DCPrime Competitive Strengths & Weaknesses
    7.9 Sanpower Corporation (Dendreon Corporation)
        7.9.1 Sanpower Corporation (Dendreon Corporation) Details
        7.9.2 Sanpower Corporation (Dendreon Corporation) Major Business
        7.9.3 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Product and Services
        7.9.4 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.9.5 Sanpower Corporation (Dendreon Corporation) Recent Developments/Updates
        7.9.6 Sanpower Corporation (Dendreon Corporation) Competitive Strengths & Weaknesses
    7.10 Elios Therapeutics
        7.10.1 Elios Therapeutics Details
        7.10.2 Elios Therapeutics Major Business
        7.10.3 Elios Therapeutics Dendritic Cell Vaccine Product and Services
        7.10.4 Elios Therapeutics Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.10.5 Elios Therapeutics Recent Developments/Updates
        7.10.6 Elios Therapeutics Competitive Strengths & Weaknesses
    7.11 ImmunoCellular Therapeutics
        7.11.1 ImmunoCellular Therapeutics Details
        7.11.2 ImmunoCellular Therapeutics Major Business
        7.11.3 ImmunoCellular Therapeutics Dendritic Cell Vaccine Product and Services
        7.11.4 ImmunoCellular Therapeutics Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.11.5 ImmunoCellular Therapeutics Recent Developments/Updates
        7.11.6 ImmunoCellular Therapeutics Competitive Strengths & Weaknesses
    7.12 Immunicum
        7.12.1 Immunicum Details
        7.12.2 Immunicum Major Business
        7.12.3 Immunicum Dendritic Cell Vaccine Product and Services
        7.12.4 Immunicum Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.12.5 Immunicum Recent Developments/Updates
        7.12.6 Immunicum Competitive Strengths & Weaknesses
    7.13 Kiromic
        7.13.1 Kiromic Details
        7.13.2 Kiromic Major Business
        7.13.3 Kiromic Dendritic Cell Vaccine Product and Services
        7.13.4 Kiromic Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.13.5 Kiromic Recent Developments/Updates
        7.13.6 Kiromic Competitive Strengths & Weaknesses
    7.14 Medigene
        7.14.1 Medigene Details
        7.14.2 Medigene Major Business
        7.14.3 Medigene Dendritic Cell Vaccine Product and Services
        7.14.4 Medigene Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.14.5 Medigene Recent Developments/Updates
        7.14.6 Medigene Competitive Strengths & Weaknesses
    7.15 Merck & Co.
        7.15.1 Merck & Co. Details
        7.15.2 Merck & Co. Major Business
        7.15.3 Merck & Co. Dendritic Cell Vaccine Product and Services
        7.15.4 Merck & Co. Dendritic Cell Vaccine Production, Price, Value, Gross Margin and Market Share (2018-2023)
        7.15.5 Merck & Co. Recent Developments/Updates
        7.15.6 Merck & Co. Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Dendritic Cell Vaccine Industry Chain
    8.2 Dendritic Cell Vaccine Upstream Analysis
        8.2.1 Dendritic Cell Vaccine Core Raw Materials
        8.2.2 Main Manufacturers of Dendritic Cell Vaccine Core Raw Materials
    8.3 Midstream Analysis
    8.4 Downstream Analysis
    8.5 Dendritic Cell Vaccine Production Mode
    8.6 Dendritic Cell Vaccine Procurement Model
    8.7 Dendritic Cell Vaccine Industry Sales Model and Sales Channels
        8.7.1 Dendritic Cell Vaccine Sales Model
        8.7.2 Dendritic Cell Vaccine Typical Customers

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Dendritic Cell Vaccine Production Value by Region (2018, 2022 and 2029) & (USD Million)
    Table 2. World Dendritic Cell Vaccine Production Value by Region (2018-2023) & (USD Million)
    Table 3. World Dendritic Cell Vaccine Production Value by Region (2024-2029) & (USD Million)
    Table 4. World Dendritic Cell Vaccine Production Value Market Share by Region (2018-2023)
    Table 5. World Dendritic Cell Vaccine Production Value Market Share by Region (2024-2029)
    Table 6. World Dendritic Cell Vaccine Production by Region (2018-2023) & (K Units)
    Table 7. World Dendritic Cell Vaccine Production by Region (2024-2029) & (K Units)
    Table 8. World Dendritic Cell Vaccine Production Market Share by Region (2018-2023)
    Table 9. World Dendritic Cell Vaccine Production Market Share by Region (2024-2029)
    Table 10. World Dendritic Cell Vaccine Average Price by Region (2018-2023) & (US$/Unit)
    Table 11. World Dendritic Cell Vaccine Average Price by Region (2024-2029) & (US$/Unit)
    Table 12. Dendritic Cell Vaccine Major Market Trends
    Table 13. World Dendritic Cell Vaccine Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
    Table 14. World Dendritic Cell Vaccine Consumption by Region (2018-2023) & (K Units)
    Table 15. World Dendritic Cell Vaccine Consumption Forecast by Region (2024-2029) & (K Units)
    Table 16. World Dendritic Cell Vaccine Production Value by Manufacturer (2018-2023) & (USD Million)
    Table 17. Production Value Market Share of Key Dendritic Cell Vaccine Producers in 2022
    Table 18. World Dendritic Cell Vaccine Production by Manufacturer (2018-2023) & (K Units)
    Table 19. Production Market Share of Key Dendritic Cell Vaccine Producers in 2022
    Table 20. World Dendritic Cell Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
    Table 21. Global Dendritic Cell Vaccine Company Evaluation Quadrant
    Table 22. World Dendritic Cell Vaccine Industry Rank of Major Manufacturers, Based on Production Value in 2022
    Table 23. Head Office and Dendritic Cell Vaccine Production Site of Key Manufacturer
    Table 24. Dendritic Cell Vaccine Market: Company Product Type Footprint
    Table 25. Dendritic Cell Vaccine Market: Company Product Application Footprint
    Table 26. Dendritic Cell Vaccine Competitive Factors
    Table 27. Dendritic Cell Vaccine New Entrant and Capacity Expansion Plans
    Table 28. Dendritic Cell Vaccine Mergers & Acquisitions Activity
    Table 29. United States VS China Dendritic Cell Vaccine Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
    Table 30. United States VS China Dendritic Cell Vaccine Production Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 31. United States VS China Dendritic Cell Vaccine Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
    Table 32. United States Based Dendritic Cell Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 33. United States Based Manufacturers Dendritic Cell Vaccine Production Value, (2018-2023) & (USD Million)
    Table 34. United States Based Manufacturers Dendritic Cell Vaccine Production Value Market Share (2018-2023)
    Table 35. United States Based Manufacturers Dendritic Cell Vaccine Production (2018-2023) & (K Units)
    Table 36. United States Based Manufacturers Dendritic Cell Vaccine Production Market Share (2018-2023)
    Table 37. China Based Dendritic Cell Vaccine Manufacturers, Headquarters and Production Site (Province, Country)
    Table 38. China Based Manufacturers Dendritic Cell Vaccine Production Value, (2018-2023) & (USD Million)
    Table 39. China Based Manufacturers Dendritic Cell Vaccine Production Value Market Share (2018-2023)
    Table 40. China Based Manufacturers Dendritic Cell Vaccine Production (2018-2023) & (K Units)
    Table 41. China Based Manufacturers Dendritic Cell Vaccine Production Market Share (2018-2023)
    Table 42. Rest of World Based Dendritic Cell Vaccine Manufacturers, Headquarters and Production Site (States, Country)
    Table 43. Rest of World Based Manufacturers Dendritic Cell Vaccine Production Value, (2018-2023) & (USD Million)
    Table 44. Rest of World Based Manufacturers Dendritic Cell Vaccine Production Value Market Share (2018-2023)
    Table 45. Rest of World Based Manufacturers Dendritic Cell Vaccine Production (2018-2023) & (K Units)
    Table 46. Rest of World Based Manufacturers Dendritic Cell Vaccine Production Market Share (2018-2023)
    Table 47. World Dendritic Cell Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 48. World Dendritic Cell Vaccine Production by Type (2018-2023) & (K Units)
    Table 49. World Dendritic Cell Vaccine Production by Type (2024-2029) & (K Units)
    Table 50. World Dendritic Cell Vaccine Production Value by Type (2018-2023) & (USD Million)
    Table 51. World Dendritic Cell Vaccine Production Value by Type (2024-2029) & (USD Million)
    Table 52. World Dendritic Cell Vaccine Average Price by Type (2018-2023) & (US$/Unit)
    Table 53. World Dendritic Cell Vaccine Average Price by Type (2024-2029) & (US$/Unit)
    Table 54. World Dendritic Cell Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 55. World Dendritic Cell Vaccine Production by Application (2018-2023) & (K Units)
    Table 56. World Dendritic Cell Vaccine Production by Application (2024-2029) & (K Units)
    Table 57. World Dendritic Cell Vaccine Production Value by Application (2018-2023) & (USD Million)
    Table 58. World Dendritic Cell Vaccine Production Value by Application (2024-2029) & (USD Million)
    Table 59. World Dendritic Cell Vaccine Average Price by Application (2018-2023) & (US$/Unit)
    Table 60. World Dendritic Cell Vaccine Average Price by Application (2024-2029) & (US$/Unit)
    Table 61. 3M Basic Information, Manufacturing Base and Competitors
    Table 62. 3M Major Business
    Table 63. 3M Dendritic Cell Vaccine Product and Services
    Table 64. 3M Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 65. 3M Recent Developments/Updates
    Table 66. 3M Competitive Strengths & Weaknesses
    Table 67. Activarti Basic Information, Manufacturing Base and Competitors
    Table 68. Activarti Major Business
    Table 69. Activarti Dendritic Cell Vaccine Product and Services
    Table 70. Activarti Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 71. Activarti Recent Developments/Updates
    Table 72. Activarti Competitive Strengths & Weaknesses
    Table 73. Argos Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 74. Argos Therapeutics Major Business
    Table 75. Argos Therapeutics Dendritic Cell Vaccine Product and Services
    Table 76. Argos Therapeutics Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 77. Argos Therapeutics Recent Developments/Updates
    Table 78. Argos Therapeutics Competitive Strengths & Weaknesses
    Table 79. Batavia Bioservices Basic Information, Manufacturing Base and Competitors
    Table 80. Batavia Bioservices Major Business
    Table 81. Batavia Bioservices Dendritic Cell Vaccine Product and Services
    Table 82. Batavia Bioservices Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 83. Batavia Bioservices Recent Developments/Updates
    Table 84. Batavia Bioservices Competitive Strengths & Weaknesses
    Table 85. Bellicum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
    Table 86. Bellicum Pharmaceuticals Major Business
    Table 87. Bellicum Pharmaceuticals Dendritic Cell Vaccine Product and Services
    Table 88. Bellicum Pharmaceuticals Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 89. Bellicum Pharmaceuticals Recent Developments/Updates
    Table 90. Bellicum Pharmaceuticals Competitive Strengths & Weaknesses
    Table 91. Creagene Basic Information, Manufacturing Base and Competitors
    Table 92. Creagene Major Business
    Table 93. Creagene Dendritic Cell Vaccine Product and Services
    Table 94. Creagene Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 95. Creagene Recent Developments/Updates
    Table 96. Creagene Competitive Strengths & Weaknesses
    Table 97. DanDrit Biotech Basic Information, Manufacturing Base and Competitors
    Table 98. DanDrit Biotech Major Business
    Table 99. DanDrit Biotech Dendritic Cell Vaccine Product and Services
    Table 100. DanDrit Biotech Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 101. DanDrit Biotech Recent Developments/Updates
    Table 102. DanDrit Biotech Competitive Strengths & Weaknesses
    Table 103. DCPrime Basic Information, Manufacturing Base and Competitors
    Table 104. DCPrime Major Business
    Table 105. DCPrime Dendritic Cell Vaccine Product and Services
    Table 106. DCPrime Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 107. DCPrime Recent Developments/Updates
    Table 108. DCPrime Competitive Strengths & Weaknesses
    Table 109. Sanpower Corporation (Dendreon Corporation) Basic Information, Manufacturing Base and Competitors
    Table 110. Sanpower Corporation (Dendreon Corporation) Major Business
    Table 111. Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Product and Services
    Table 112. Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 113. Sanpower Corporation (Dendreon Corporation) Recent Developments/Updates
    Table 114. Sanpower Corporation (Dendreon Corporation) Competitive Strengths & Weaknesses
    Table 115. Elios Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 116. Elios Therapeutics Major Business
    Table 117. Elios Therapeutics Dendritic Cell Vaccine Product and Services
    Table 118. Elios Therapeutics Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 119. Elios Therapeutics Recent Developments/Updates
    Table 120. Elios Therapeutics Competitive Strengths & Weaknesses
    Table 121. ImmunoCellular Therapeutics Basic Information, Manufacturing Base and Competitors
    Table 122. ImmunoCellular Therapeutics Major Business
    Table 123. ImmunoCellular Therapeutics Dendritic Cell Vaccine Product and Services
    Table 124. ImmunoCellular Therapeutics Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 125. ImmunoCellular Therapeutics Recent Developments/Updates
    Table 126. ImmunoCellular Therapeutics Competitive Strengths & Weaknesses
    Table 127. Immunicum Basic Information, Manufacturing Base and Competitors
    Table 128. Immunicum Major Business
    Table 129. Immunicum Dendritic Cell Vaccine Product and Services
    Table 130. Immunicum Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 131. Immunicum Recent Developments/Updates
    Table 132. Immunicum Competitive Strengths & Weaknesses
    Table 133. Kiromic Basic Information, Manufacturing Base and Competitors
    Table 134. Kiromic Major Business
    Table 135. Kiromic Dendritic Cell Vaccine Product and Services
    Table 136. Kiromic Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 137. Kiromic Recent Developments/Updates
    Table 138. Kiromic Competitive Strengths & Weaknesses
    Table 139. Medigene Basic Information, Manufacturing Base and Competitors
    Table 140. Medigene Major Business
    Table 141. Medigene Dendritic Cell Vaccine Product and Services
    Table 142. Medigene Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 143. Medigene Recent Developments/Updates
    Table 144. Merck & Co. Basic Information, Manufacturing Base and Competitors
    Table 145. Merck & Co. Major Business
    Table 146. Merck & Co. Dendritic Cell Vaccine Product and Services
    Table 147. Merck & Co. Dendritic Cell Vaccine Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
    Table 148. Global Key Players of Dendritic Cell Vaccine Upstream (Raw Materials)
    Table 149. Dendritic Cell Vaccine Typical Customers
    Table 150. Dendritic Cell Vaccine Typical Distributors
List of Figure
    Figure 1. Dendritic Cell Vaccine Picture
    Figure 2. World Dendritic Cell Vaccine Production Value: 2018 & 2022 & 2029, (USD Million)
    Figure 3. World Dendritic Cell Vaccine Production Value and Forecast (2018-2029) & (USD Million)
    Figure 4. World Dendritic Cell Vaccine Production (2018-2029) & (K Units)
    Figure 5. World Dendritic Cell Vaccine Average Price (2018-2029) & (US$/Unit)
    Figure 6. World Dendritic Cell Vaccine Production Value Market Share by Region (2018-2029)
    Figure 7. World Dendritic Cell Vaccine Production Market Share by Region (2018-2029)
    Figure 8. North America Dendritic Cell Vaccine Production (2018-2029) & (K Units)
    Figure 9. Europe Dendritic Cell Vaccine Production (2018-2029) & (K Units)
    Figure 10. China Dendritic Cell Vaccine Production (2018-2029) & (K Units)
    Figure 11. Japan Dendritic Cell Vaccine Production (2018-2029) & (K Units)
    Figure 12. Dendritic Cell Vaccine Market Drivers
    Figure 13. Factors Affecting Demand
    Figure 14. World Dendritic Cell Vaccine Consumption (2018-2029) & (K Units)
    Figure 15. World Dendritic Cell Vaccine Consumption Market Share by Region (2018-2029)
    Figure 16. United States Dendritic Cell Vaccine Consumption (2018-2029) & (K Units)
    Figure 17. China Dendritic Cell Vaccine Consumption (2018-2029) & (K Units)
    Figure 18. Europe Dendritic Cell Vaccine Consumption (2018-2029) & (K Units)
    Figure 19. Japan Dendritic Cell Vaccine Consumption (2018-2029) & (K Units)
    Figure 20. South Korea Dendritic Cell Vaccine Consumption (2018-2029) & (K Units)
    Figure 21. ASEAN Dendritic Cell Vaccine Consumption (2018-2029) & (K Units)
    Figure 22. India Dendritic Cell Vaccine Consumption (2018-2029) & (K Units)
    Figure 23. Producer Shipments of Dendritic Cell Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
    Figure 24. Global Four-firm Concentration Ratios (CR4) for Dendritic Cell Vaccine Markets in 2022
    Figure 25. Global Four-firm Concentration Ratios (CR8) for Dendritic Cell Vaccine Markets in 2022
    Figure 26. United States VS China: Dendritic Cell Vaccine Production Value Market Share Comparison (2018 & 2022 & 2029)
    Figure 27. United States VS China: Dendritic Cell Vaccine Production Market Share Comparison (2018 & 2022 & 2029)
    Figure 28. United States VS China: Dendritic Cell Vaccine Consumption Market Share Comparison (2018 & 2022 & 2029)
    Figure 29. United States Based Manufacturers Dendritic Cell Vaccine Production Market Share 2022
    Figure 30. China Based Manufacturers Dendritic Cell Vaccine Production Market Share 2022
    Figure 31. Rest of World Based Manufacturers Dendritic Cell Vaccine Production Market Share 2022
    Figure 32. World Dendritic Cell Vaccine Production Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 33. World Dendritic Cell Vaccine Production Value Market Share by Type in 2022
    Figure 34. Non-Targeted
    Figure 35. Target
    Figure 36. World Dendritic Cell Vaccine Production Market Share by Type (2018-2029)
    Figure 37. World Dendritic Cell Vaccine Production Value Market Share by Type (2018-2029)
    Figure 38. World Dendritic Cell Vaccine Average Price by Type (2018-2029) & (US$/Unit)
    Figure 39. World Dendritic Cell Vaccine Production Value by Application, (USD Million), 2018 & 2022 & 2029
    Figure 40. World Dendritic Cell Vaccine Production Value Market Share by Application in 2022
    Figure 41. Covid-19
    Figure 42. Cancer
    Figure 43. Others
    Figure 44. World Dendritic Cell Vaccine Production Market Share by Application (2018-2029)
    Figure 45. World Dendritic Cell Vaccine Production Value Market Share by Application (2018-2029)
    Figure 46. World Dendritic Cell Vaccine Average Price by Application (2018-2029) & (US$/Unit)
    Figure 47. Dendritic Cell Vaccine Industry Chain
    Figure 48. Dendritic Cell Vaccine Procurement Model
    Figure 49. Dendritic Cell Vaccine Sales Model
    Figure 50. Dendritic Cell Vaccine Sales Channels, Direct Sales, and Distribution
    Figure 51. Methodology
    Figure 52. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

3M
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation (Dendreon Corporation)
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck & Co.

Related Reports

Global Dendritic Cell Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Dendritic Cell Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 06 Sep 2023

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Dendritic Cell Vaccine market size was valued at USD 65 million in 2022 and is forecast to a readjusted size of USD 80 million by 2029 with a CAGR of 3.0% during review period.

Global Dendritic Cell Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Dendritic Cell Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 10 Jan 2024

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Dendritic Cell Vaccine market size was valued at USD 65 million in 2023 and is forecast to a readjusted size of USD 80 million by 2030 with a CAGR of 3.0% during review period.

Global Dendritic Cell Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

Global Dendritic Cell Vaccine Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

date 13 Jan 2025

date Pharma & Healthcare

According to our (Global Info Research) latest study, the global Dendritic Cell Vaccine market size was valued at US$ 70.9 million in 2024 and is forecast to a readjusted size of USD 87.1 million by 2031 with a CAGR of 3.0% during review period.

Product Tags

Dendritic Cell Vaccine

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD4480.00

Multi User License

USD6720.00

Corporate Users License

USD8960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>